# Liver Function Test (LFT) Elevations in Cancer Patients and Users of Tyrosine Kinase Inhibitor (TKI) Drugs

> **NCT01098500** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 3800 (actual)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** Tyrosine kinase inhibitors

## Key facts

- **NCT ID:** NCT01098500
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 3800 (ACTUAL)
- **Last updated:** 2017-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01098500

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01098500, "Liver Function Test (LFT) Elevations in Cancer Patients and Users of Tyrosine Kinase Inhibitor (TKI) Drugs". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01098500. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*